// App-Quantinova.ai

e21040 : Liquid chromatography coupled to multiple reaction monitoring (LC-MRM) for quantification of PD-L1 and PD1-signaling proteins in non-small cell lung carcinoma (NSCLC).

Researchers

Presenter

  • Vincent Lacasse

Principal Investigators

  • Rene Zahedi

  • Vincent Richard

  • Hangjun Wang

  • Georgia Mitsa

  • Olivier Poetz

  • Margaret Redpath

  • Andreas Papadakis

  • Mounib Elchebly

  • Victor Cohen

  • Jason Scott Agulnik

  • Gerald Batist

  • Christopher Borchers

  • Alan Spatz

Medical Centers

  • Medecine, Lady David Institute, McGill University, Montreal, QC, Canada

  • Lady Davis Institute, Montreal, Quebec, Canada

  • Jewish General Hospital, Lady Davis Institute, McGill University Health Center, McGill University, Montreal, QC, Canada

  • SIGNATOPE GmbH, Reutlingen, Germany

  • Jewish General Hospital, Montreal, QC, Canada

  • Segal Cancer Center/Jewish General Hospital, McGill University, Montreal, QC, Canada

  • Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • 5'-nucleotidase

  • Programmed cell death 1 ligand 2

  • Programmed cell death protein 1

  • Programmed death-ligand 1

Drug/Treatment

  • ZAP70

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved